Mahesh Karande

Mahesh Karande

Chief Executive Officer at OMEGA THERAPEUTICS, INC.

Net worth: - $ as of 2024-03-30

51 year
Health Technology
Consumer Services
Retail Trade

Profile

Mahesh Karande is currently the President, Chief Executive Officer & Director at Omega Therapeutics, Inc., as well as a Director at Ashvattha Therapeutics Inc and KSQ Therapeutics, Inc. Prior to his current roles, he was the President & Chief Executive Officer at Zikani Therapeutics, Inc. and held various leadership positions at Novartis, Inc., Novartis SA, and Novartis Pharma SAE.
He has a graduate degree from Georgia Institute of Technology, an undergraduate degree from the University of Mumbai, and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-06 0 ( -.--% ) - $ 2024-03-30

Mahesh Karande active positions

CompaniesPositionStart
OMEGA THERAPEUTICS, INC. Chief Executive Officer 2019-05-31
Director/Board Member 2022-12-07
Director/Board Member 2023-05-30
All active positions of Mahesh Karande

Former positions of Mahesh Karande

CompaniesPositionEnd
Chief Executive Officer 2019-02-28
Novartis Pharma SAE President 2017-03-31
President 2017-03-31
Corporate Officer/Principal 2017-03-31
See the detail of Mahesh Karande's experience

Training of Mahesh Karande

Georgia Institute of Technology Graduate Degree
University of Mumbai Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mahesh Karande's experience

Connections

45

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
OMEGA THERAPEUTICS, INC.

Health Technology

Private companies6

Health Technology

Retail Trade

Health Technology

Novartis Pharma SAE

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Mahesh Karande